Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

28 Aug 2018

A look at recent M&A activity in the CMO sector

When Catalent announced the completion of its acquisition of Juniper Pharma in mid-August, it was the latest deal in a…

17 May 2018

Breaking Down The Trump Administrations’ Proposed Initiatives to Address High Pharma Prices

Last Friday in the White House Rose Garden, President Trump delivered remarks outlining his administration’s plans to lower drug prices…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

Insights

Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office